Innate inflammatory responses to the Gram-positive bacterium Lactococcus lactis

Area of Science:

• Immunology
• Microbiology
• Vaccinology

Background:

• Lactococcus lactis is a common dairy bacterium with potential applications as an oral live vaccine.
• Investigating the adjuvant properties of L. lactis is crucial for its vaccine development.
• Adjuvants enhance vaccine efficacy by stimulating immune responses.

Purpose of the Study:

• To evaluate the adjuvant properties of Lactococcus lactis.
• To compare the proinflammatory effects of L. lactis with Gram-negative bacteria like Escherichia coli and Salmonella typhi.
• To assess the induction of chemokines by these bacteria in immune cells.

Main Methods:

• Gene expression profiling of chemokines in macrophages (in vitro) and murine air-pouch cells (in vivo).
• Co-incubation of bacteria with dendritic cells (DCs) derived from mouse bone marrow.
• Comparative analysis of inflammatory responses induced by L. lactis, E. coli, and S. typhi.

Main Results:

• Lactococcus lactis demonstrated significant proinflammatory effects.
• Gene expression analysis revealed chemokine induction by L. lactis in both in vitro and in vivo models.
• L. lactis modulated dendritic cell activity, suggesting immune-stimulating capabilities.

Conclusions:

• Lactococcus lactis possesses inherent proinflammatory properties.
• These findings support the potential of L. lactis as an adjuvant in vaccine formulations.
• L. lactis could enhance the immunogenicity of oral live vaccines.